癌症
乳腺癌
癌症研究
程序性细胞死亡
肿瘤科
医学
免疫学
内科学
细胞凋亡
生物
生物化学
作者
Mustafa Emre Gedik,Özge Saatci,Nathaniel P. Oberholtzer,Meral Üner,Özge Akbulut,Metin Çetįn,Mertkaya Aras,Kübra İbiş,Burcu Çalışkan,Erden Banoğlu,Stefan Wiemann,Ayşegül Üner,Sercan Aksoy,Shikhar Mehrotra,Özgür Şahin
出处
期刊:Cancer Research
[American Association for Cancer Research]
日期:2024-02-06
卷期号:84 (9): 1475-1490
被引量:47
标识
DOI:10.1158/0008-5472.can-23-2812
摘要
Trastuzumab emtansine (T-DM1) was the first and one of the most successful antibody-drug conjugates (ADC) approved for treating refractory HER2-positive breast cancer. Despite its initial clinical efficacy, resistance is unfortunately common, necessitating approaches to improve response. Here, we found that in sensitive cells, T-DM1 induced spindle assembly checkpoint (SAC)-dependent immunogenic cell death (ICD), an immune-priming form of cell death. The payload of T-DM1 mediated ICD by inducing eIF2α phosphorylation, surface exposure of calreticulin, ATP and HMGB1 release, and secretion of ICD-related cytokines, all of which were lost in resistance. Accordingly, ICD-related gene signatures in pretreatment samples correlated with clinical response to T-DM1-containing therapy, and increased infiltration of antitumor CD8+ T cells in posttreatment samples was correlated with better T-DM1 response. Transforming acidic coiled-coil containing 3 (TACC3) was overexpressed in T-DM1-resistant cells, and T-DM1 responsive patients had reduced TACC3 protein expression whereas nonresponders exhibited increased TACC3 expression during T-DM1 treatment. Notably, genetic or pharmacologic inhibition of TACC3 restored T-DM1-induced SAC activation and induction of ICD markers in vitro. Finally, TACC3 inhibition in vivo elicited ICD in a vaccination assay and potentiated the antitumor efficacy of T-DM1 by inducing dendritic cell maturation and enhancing intratumoral infiltration of cytotoxic T cells. Together, these results illustrate that ICD is a key mechanism of action of T-DM1 that is lost in resistance and that targeting TACC3 can restore T-DM1-mediated ICD and overcome resistance. SIGNIFICANCE: Loss of induction of immunogenic cell death in response to T-DM1 leads to resistance that can be overcome by targeting TACC3, providing an attractive strategy to improve the efficacy of T-DM1.
科研通智能强力驱动
Strongly Powered by AbleSci AI